key: cord-0968127-emrigwt7
authors: Shaikh, Nissar; Al Ameri, Gamal; Shaheen, Muhsen; Abdaljawad, Wael I.; Al Wraidat, Mohammad; Al Alawi, Abdul Aziz S.; Ali, Husain S.; Mohamed, Ahmed S.; Daeri, Hazem; Khatib, Mohamad Y.; Elshafei, Moustafa S.; Nashwan, Abdulqadir J.
title: Spontaneous pneumomediastinum and pneumothorax in COVID‐19 patients: A tertiary care experience
date: 2021-07-30
journal: Health Sci Rep
DOI: 10.1002/hsr2.339
sha: 6fab72d2b78f1a70a15d659df39a21e63c88c678
doc_id: 968127
cord_uid: emrigwt7

INTRODUCTION: COVID‐19 can occasionally complicate into spontaneous pneumothorax (SP) and/or spontaneous pneumomediastinum (SM). This study aims at exploring the occurrence of SP and or SM, risk factors, and outcomes in COVID‐19 patients. MATERIALS AND METHODS: All patients with COVID‐19, which complicated into SP and/or SM at Hamad Medical Corporation (the principal public healthcare provider in Qatar) from March to September 2020, were retrospectively enrolled. The clinical diagnosis was confirmed by CXR and CT. Between‐group comparisons were performed by using Chi‐square and t‐test. Differences were considered statistically significant at P ≤ .05. RESULTS: A total of 1100 patients were admitted, and 43 patients developed SP, SP + SM, or SM. Most patients were males (42/97.9%), and the most common comorbidity was diabetes mellitus (13/30.2%). All patients had acute respiratory distress syndrome (ARDS), and most patients had low lung compliance at the time of developing SP or SM. Twenty‐two of the patients developed SP (51.2%), 11 patients had both SP and SM (25.6%), and 10 patients had SM only (23.3%). There was no significant difference in the development of SP or SM and patients' gender or blood group or whether patients were on invasive or noninvasive ventilation or even the mortality (P > .05). Lung compliance was significantly (P < .05) lower in patients complicated with SP and or SM. Patients with SP required significantly higher (P < .001) chest drain insertion. CONCLUSION: Patients with severe COVID‐19 pneumonia can complicate into SP and SM. These complications are more common in male diabetic patients. Patients with ARDS and having low lung compliance are at a higher risk of developing SP, SP + SM, or SM.

In late 2019, the occurrence of pneumonia of unknown origin was detected in China. Despite various mitigation and control measures, the disease has spread quickly and extensively across the world and was characterized by the World Health Organization as a global pandemic in early 2020. 1 Later, the disease was found to be caused by a novel coronavirus SARS-CoV-2 and was named coronavirus disease-2019 (COVID-19). 1 This pandemic resulted in significant morbidity, mortality, and financial losses globally. 1 COVID-19 pneumonia can frequently and rapidly complicate into ARDS, and such patients may require noninvasive and/or invasive forms of ventilation. 1,2 Spontaneous pneumothorax (SP) and or spontaneous pneumomediastinum (SM) are occasionally found clinical entities and occur in 1% to 2% of the COVID-19 patients without any traumatic cause. Initially, the occurrence of SP and SM was thought to be related to invasive ventilation-induced events but have recently been reported to occur without evidence of barotrauma or volume trauma. In addition, some cases have occurred even before the initiation of invasive mechanical ventilation. 3 The aim of our study was to examine the occurrence, risk factors, and outcome of COVID-19 patients complicating with SP and pneumomediastinum.

After obtaining permission for the study from the medical research department of our institution, all COVID-19 patients with pneumonia and or ARDS who developed a SP or pneumomediastinum (SM) from March to September 2020 were enrolled retrospectively in this study.

The diagnosis of SP or SM was confirmed by chest x-ray and/or chest computerized tomography (CT). In addition, patients' demographic data, the severity of the disease, respiratory support mode, positive end-expiratory pressure, P/F ratios, lung compliance values, insertion of intercostal drains, and outcomes were recorded from the electronic health records retrospectively. 

In pediatric patients, pneumothorax or pneumomediastinum caused by iatrogenic reasons such as invasive procedures was excluded from the study.

Data were entered in SPSS version 23. Categorical variables were reported as frequency (n) and percentage (%), whereas continuous variables were reported as mean and standard deviation (SD). The Kolmogorov-Smirnov test proved these variables to be normally distributed. Comparisons between the groups were performed by chi-square test for categorical variables and the t-test for continuous variables. Differences were considered statistically significant at P ≤ .05.

During the study period, a total of 1100 COVID-19 patients were admitted to the intensive care unit of our hospital, and only 43 patients (3.9%) had SP and/or SM. The majority of the patients were male (42/97.7%), and the most frequent comorbidity was diabetes mellitus (13/30.2%). Blood group "A" was the most frequent, whereas type "O" blood group was the least frequent in patients who developed SP and SM. (Table 1 ) Most of the patients had sequential organ failure assessment (SOFA) score of less than 6 (37/86%). In the majority of patients (35/81.4%), the partial pressure of oxygen to fraction of inspired oxygen ratio (P/F) was less than 150, making the diag- Table 1 ). In the majority of patients, the positive endexpiratory pressure (PEEP) was less than 10 cm of H 2 0. Thirty-four patients (79%) had low lung compliance of less or equal to 25 mL/cm of H 2 0 (Table 1) . Twenty-nine (67.4%) patients required intercostal drain insertion as a management of their pneumothorax (Table 1) .

Twenty-two (52.4%) patients had only pneumothorax (SP), 11 (26.2%) had both pneumothorax and pneumomediastinum (SP and SM), whereas 10 (23.3%) patients had pneumomediastinum only (SM) ( Table 2 ). There was no significant difference in the occurrence of SP and SM according to gender and blood group (P = .11 and 0.34, respectively). The SOFA score on admission was significantly low (P < .03) in patients who developed SP, SP + SM, and SM. There was no significant difference in the patient's comorbidities and development of SP, SP + SM, and SM (Table 2 ). There was no significant difference in the mode of ventilation or respiratory support, namely HFNC, NIV, or intubation and invasive ventilation and development of SP, SP + SM, and SM (P = .4/.9/.7 respectively). The level of PEEP was not associated with or increased the risk of development of SP, SP + SM, or SM (P = .4) ( Table 2 ). Prone position was not associated with significantly increased risk for development of SP, SP + SM, or SM (P = .4). Lung compliance was significantly low (P = .05) in patients developing SP, SP + SM, or SM. Patients developing SP required significantly higher (P < .001) chest drain insertion as a therapeutic approach compared to SP + SM or SM ( 8 Male patients were the majority in our study as well.

In our patient population, a majority had SP (51.2%), followed by SP + SM (25.6) and only SM (23.3%). Martinelli et al reported SP frequent in their COVID-19 patients followed by SM (60 and 11 patients, respectively). 9 Noppen and Sahni both reported that asthma, chronic Obstructive pulmonary disease (COPD), and tobacco-chewing are the risk factors for the development of SP and SM. 10, 11 In our study, there was no impact on patients' comorbidities on the development of SP or SM or both. Martinelli et al did not find any correlation between the development of SP or SM and the comorbidities. 9 Patients with blood group "A" are at a higher risk of getting COVID-19 infection compared to the other blood groups. 12 In our patients, however, SP and SM occurred more frequently in patients with blood group "A," but there was no significant correlation between the patients' blood group and SP and SM development.

Our patients' disease severity score (SOFA score < 6) was low on admission, the worst SOFA score was higher (11.7) as these patients were complicated with SP and SM.

As described in the literature, 3, 9 SP and SM can develop without invasive ventilation, but the majority of the patients were intubated and ventilated. In our study, also most of the patients were intubated and ventilated.

The majority of our patients had ARDS according to the P/F ratio and low lung compliance; this might have triggered the lung parenchymal changes and bullae formation, causing air leak, complicating into the development of SP and SM. 13 More than 60% of our patients with SP and SM required treatment with intercostal drain insertion and predominantly were with SP. Literature also suggests that both conservative or chest drain guided management for SP and SM in COVID-19

patients. 3, 9, 13 The literature describes that COVID-19 pneumonia complicated by the development of SP and SM increases mortality. 3, 13 In our patient series, there was increased mortality of COVID ACKNOWLEDGMENT Open Access funding provided by the Qatar National Library.

The authors declare that they have no competing interests. All authors read and approved the final manuscript.

Not applicable.

This manuscript is an honest, accurate, and transparent account of the study being reported; no important aspects of the study have been omitted; and no any discrepancies from the study as planned have been explained.

All data generated or analyzed during this study are included in this published article.

The project has been approved by the Medical Research Center 

Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19 pneumonia: a rare case and literature review

Comparison of the clinical outcomes of noninvasive ventilation by helmet vs facemask in patients with acute respiratory distress syndrome

Pneumothorax and pneumomediastinum secondary to COVID-19 disease unrelated to mechanical ventilation. Case Rep Critic Care

Spontaneous pneumomediastinum emphysema

Tension pneumomediastinum. A literal form of chest tightness

Malignant interstitial emphysema of the lungs and mediastinum as important occult complication in many respiratory disease and other conditions: interpretation of clinical literature in the light of laboratory experiment

Systemic review of spontaneous pneumomediastinum: a survey of 22 years data

Case report: pneumothorax and Pneumomediastinum as uncommon complications of COVID-19 pneumonia-literature review

COVID-19 and pneumothorax: a multicentre retrospective case series

Spontaneous pneumothorax: epidemiology, pathophysiology and cause

Spontaneous pneumomediastinum: time for consensus

Reduced prevalence of SARS-CoV-2 infection in ABO blood group O

Spontaneous pneumomediastinum and pneumothorax in COVID-19 patients: A tertiary care experience

Ahmed S. Mohamed https://orcid.org/0000-0002-2107-5357Abdulqadir J. Nashwan https://orcid.org/0000-0003-4845-4119